Tissue factors from the family of adipocytokines that regulate lipid metabolism such as adiponectin and resistin are expressed in ovarian cancer cells and can drive tumor progression (Dogra et al., 2021). This evidence concerns the gene ADIPOQ and ovarian carcinoma.